Similar articles for PMID: 33547214

Year	Number of Results
2012	2
2013	3
2014	1
2015	4
2016	10
2017	17
2018	19
2019	22
2020	30
2021	36
2022	27
2023	6
2024	1

1

Combination of Forced Diuresis with Additional Late Imaging in ⁶⁸Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake.

Alberts I, Niklas-Hünermund J, Sachpekidis C, Zacho HD, Mingels C, Dijkstra L, Bohn KP, Läppchen T, Gourni E, Rominger A, Afshar-Oromieh A. Alberts I, et al. J Nucl Med. 2021 Sep 1;62(9):1252-1257. doi: 10.2967/jnumed.120.257741. Epub 2021 Feb 5. J Nucl Med. 2021. PMID: 33547214 Free article.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for ⁶⁸Ga-PSMA-11 PET/CT.

Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka H, Decristoforo C, von Guggenberg E, Horninger W, Virgolini IJ. Uprimny C, et al. J Nucl Med. 2021 Nov;62(11):1550-1557. doi: 10.2967/jnumed.120.261866. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712533 Free PMC article.

4

Combined forced diuresis and late acquisition on [⁶⁸Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study.

Bauckneht M, Miceli A, Signori A, Albano D, Capitanio S, Piva R, Laudicella R, Franchini A, D'Amico F, Riondato M, Chiola S, Marini C, Fornarini G, Scarale A, Muni A, Bertagna F, Burger IA, Sambuceti G, Morbelli S. Bauckneht M, et al. Eur Radiol. 2023 May;33(5):3343-3353. doi: 10.1007/s00330-023-09516-0. Epub 2023 Mar 9. Eur Radiol. 2023. PMID: 36892650 Free PMC article.

5

⁶⁸Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.

Haupt F, Dijkstra L, Alberts I, Sachpekidis C, Fech V, Boxler S, Gross T, Holland-Letz T, Zacho HD, Haberkorn U, Rahbar K, Rominger A, Afshar-Oromieh A. Haupt F, et al. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):624-631. doi: 10.1007/s00259-019-04548-5. Epub 2019 Nov 1. Eur J Nucl Med Mol Imaging. 2020. PMID: 31673789 Free article.

6

Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [⁶⁸Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.

Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka A, Decristoforo C, di Santo G, von Guggenberg E, Horninger W, Virgolini IJ. Uprimny C, et al. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):123-133. doi: 10.1007/s00259-020-04846-3. Epub 2020 May 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32385647

7

The Clinical Impact of Additional Late PET/CT Imaging with ⁶⁸Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer.

Afshar-Oromieh A, Sattler LP, Mier W, Hadaschik BA, Debus J, Holland-Letz T, Kopka K, Haberkorn U. Afshar-Oromieh A, et al. J Nucl Med. 2017 May;58(5):750-755. doi: 10.2967/jnumed.116.183483. Epub 2017 Jan 6. J Nucl Med. 2017. PMID: 28062595 Free article. Clinical Trial.

8

⁶⁸Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging.

Derlin T, Weiberg D, von Klot C, Wester HJ, Henkenberens C, Ross TL, Christiansen H, Merseburger AS, Bengel FM. Derlin T, et al. Eur Radiol. 2016 Dec;26(12):4345-4353. doi: 10.1007/s00330-016-4308-4. Epub 2016 Mar 24. Eur Radiol. 2016. PMID: 27011373

9

Determination of optimal ⁶⁸ Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT.

Wen J, Zhu Y, Li L, Liu J, Chen Y, Chen R. Wen J, et al. Eur J Nucl Med Mol Imaging. 2022 May;49(6):2086-2095. doi: 10.1007/s00259-021-05659-8. Epub 2021 Dec 28. Eur J Nucl Med Mol Imaging. 2022. PMID: 34962583

10

Combined Early and Late [⁶⁸Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels.

Hohberg M, Kobe C, Täger P, Hammes J, Schmidt M, Dietlein F, Wild M, Heidenreich A, Drzezga A, Dietlein M. Hohberg M, et al. Mol Imaging Biol. 2019 Jun;21(3):558-566. doi: 10.1007/s11307-018-1263-2. Mol Imaging Biol. 2019. PMID: 30105521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year